Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Key International (BKYI) EPS (Basic) (2016 - 2025)

Bio Key International (BKYI) has disclosed EPS (Basic) for 16 consecutive years, with -$0.15 as the latest value for Q3 2025.

  • Quarterly EPS (Basic) rose 61.54% to -$0.15 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$0.91 through Sep 2025, up 85.15% year-over-year, with the annual reading at -$2.09 for FY2024, 86.26% up from the prior year.
  • EPS (Basic) hit -$0.15 in Q3 2025 for Bio Key International, up from -$0.2 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.11 in Q1 2021 to a low of -$26.62 in Q4 2022.
  • Historically, EPS (Basic) has averaged -$2.4 across 5 years, with a median of -$0.29 in 2022.
  • Biggest five-year swings in EPS (Basic): soared 94.02% in 2021 and later tumbled 10138.46% in 2022.
  • Year by year, EPS (Basic) stood at -$0.26 in 2021, then crashed by 10138.46% to -$26.62 in 2022, then soared by 83.4% to -$4.42 in 2023, then skyrocketed by 90.95% to -$0.4 in 2024, then skyrocketed by 62.5% to -$0.15 in 2025.
  • Business Quant data shows EPS (Basic) for BKYI at -$0.15 in Q3 2025, -$0.2 in Q2 2025, and -$0.16 in Q1 2025.